Literature DB >> 8996191

Effect of prenatal fluoxetine (Prozac) exposure on brain serotonin neurons in prepubescent and adult male rat offspring.

T M Cabrera-Vera1, F Garcia, W Pinto, G Battaglia.   

Abstract

The present study examines the consequences of prenatal fluoxetine exposure on brain serotonin [5-hydroxytryptamine (5-HT)] neurons in male offspring. Pregnant rats were administered either saline or fluoxetine (10 mg/kg s.c.) daily from gestational day 13 through gestational day 20. The biochemical status of brain 5-HT neurons was assessed in prepubescent and adult offspring by measuring 1) the 5-HT and 5-hydroxyindoleacetic acid content, 2) the density of [3H]paroxetine-labeled 5-HT uptake sites and 3) the ability of the 5-HT-releasing drug p-chloroamphetamine to reduce 5-HT content. Biochemical parameters were assessed in the frontal cortex, hypothalamus, hippocampus, striatum and midbrain. Comparative effects on dopamine and norepinephrine content in selected regions were also determined. Prenatal exposure to fluoxetine significantly reduced (-28%) 5-HT content in the frontal cortex of prepubescent but not adult male offspring. In contrast, in adult progeny prenatal fluoxetine exposure produced a significant decrease only in midbrain 5-HT content (-28%). In addition, p-chloroamphetamine markedly reduced 5-HT content in all brain regions examined, but the ability of p-chloroamphetamine to reduce 5-HT content was significantly attenuated only in the midbrain of adult progeny prenatally exposed to fluoxetine. No significant differences were observed between control and fluoxetine-exposed progeny with respect to brain 5-hydroxyindoleacetic acid content, the 5-hydroxyindoleacetic acid/5-HT ratio or the density of 5-HT uptake sites, regardless of the brain region examined or the age of the offspring. These data provide additional evidence that prenatal exposure to fluoxetine can produce limited, rather than global, changes in brain 5-HT neurons in male rat offspring and that the effects observed are region-specific and age-dependent. The potential functional consequences and clinical implications of these alterations in brain 5-HT systems remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8996191

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  Prenatal exposure to escitalopram and/or stress in rats: a prenatal stress model of maternal depression and its treatment.

Authors:  Chase H Bourke; Catherine F Capello; Swati M Rogers; Megan L Yu; Katherine A Boss-Williams; Jay M Weiss; Zachary N Stowe; Michael J Owens
Journal:  Psychopharmacology (Berl)       Date:  2013-02-24       Impact factor: 4.530

Review 2.  Prenatal antidepressant exposure: clinical and preclinical findings.

Authors:  Chase H Bourke; Zachary N Stowe; Michael J Owens
Journal:  Pharmacol Rev       Date:  2014-02-24       Impact factor: 25.468

Review 3.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

4.  The effects of perinatal fluoxetine treatment on the circadian system of the adult mouse.

Authors:  Veronika Kiryanova; Victoria M Smith; Richard H Dyck; Michael C Antle
Journal:  Psychopharmacology (Berl)       Date:  2012-09-13       Impact factor: 4.530

5.  Prenatal exposure to escitalopram and/or stress in rats produces limited effects on endocrine, behavioral, or gene expression measures in adult male rats.

Authors:  Chase H Bourke; Zachary N Stowe; Gretchen N Neigh; Darin E Olson; Michael J Owens
Journal:  Neurotoxicol Teratol       Date:  2013-07-30       Impact factor: 3.763

Review 6.  Modulation of prenatal stress via docosahexaenoic acid supplementation: implications for child mental health.

Authors:  Kate Keenan; Alison E Hipwell
Journal:  Nutr Rev       Date:  2015-02-13       Impact factor: 7.110

7.  Serotonin transporter occupancy in rats exposed to serotonin reuptake inhibitors in utero or via breast milk.

Authors:  Catherine F Capello; Chase H Bourke; James C Ritchie; Zachary N Stowe; D Jeffrey Newport; Amanda Nemeroff; Michael J Owens
Journal:  J Pharmacol Exp Ther       Date:  2011-07-20       Impact factor: 4.030

8.  Examining the Reversibility of Long-Term Behavioral Disruptions in Progeny of Maternal SSRI Exposure.

Authors:  Susan E Maloney; Shyam Akula; Michael A Rieger; Katherine B McCullough; Krystal Chandler; Adrian M Corbett; Audrey E McGowin; Joseph D Dougherty
Journal:  eNeuro       Date:  2018-07-09

9.  Neurobehavioral manifestations of developmental impairment of the brain.

Authors:  Michal Dubovický
Journal:  Interdiscip Toxicol       Date:  2010-06

10.  Long-term effects of fluoxetine or vehicle administration during pregnancy on behavioral outcomes in guinea pig offspring.

Authors:  Raphael Vartazarmian; Saima Malik; Glen B Baker; Patricia Boksa
Journal:  Psychopharmacology (Berl)       Date:  2004-09-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.